Andrew Hirsch, C4 Therapeutics CEO (Endpoints file photo; Christine Hochkeppel)
Longtime biotech vet Andrew Hirsch is taking the top job at C4 — and he clearly has some big plans
Four years after Andrew Hirsch tied the last loose end on Bind’s bankruptcy package and shipped to Agios as its CFO, he is back at …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
